trending Market Intelligence /marketintelligence/en/news-insights/trending/kHjGXtSyu68gcoalp_j4gg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Ascendis Pharma closes ADS offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Ascendis Pharma closes ADS offering

Ascendis Pharma A/S closed an underwritten public offering of 3.8 million American depositary shares for net proceeds of about $126.1 million.

The company priced the ADSs, each of which represents 1 ordinary share, at $35.50 apiece.

Underwriters also received a 30-day option to buy up to an additional 570,000 ADSs.

Underwriters were J.P. Morgan Securities LLC, Merrill Lynch, Pierce Fenner & Smith Inc., Credit Suisse Securities (USA) LLC, Wells Fargo Securities LLC and Wedbush Securities Inc.